| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-20,841.76 | -17,102.38 | -10,924.14 | -7,484.11 | -3,987.60 |
|
Research and Development Expenses
|
-36,264.18 | -21,331.66 | -16,079.28 | -20,363.12 | -13,629.85 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -- | -148.34 |
|
Operating Income/Expenses
|
-57,105.94 | -38,434.04 | -27,003.41 | -27,847.23 | -17,617.45 |
|
Total Operating Profit/Loss
|
-57,105.94 | -38,434.04 | -27,003.41 | -27,847.23 | -17,617.45 |
| Total Net Finance Income/Expense
|
3,313.11 | 1,412.52 | 556.37 | -307.20 | -551.06 |
| Net Investment Income
|
3,613.05 | -1,562.48 | 1,041.33 | -770.30 | -815.62 |
| Irregular Income/Expenses
|
-4.19 | -2.56 | -336.97 | -4.85 | -6.64 |
|
Other Income/Expense, Non-Operating
|
-- | -- | -- | -- | 0 |
|
Non-Operating Income/Expenses, Total
|
6,921.97 | -152.52 | 1,260.73 | -1,082.35 | -1,373.31 |
|
Pretax Income
|
-50,183.97 | -38,586.56 | -25,742.69 | -28,929.58 | -18,990.76 |
|
Provision for Income Tax
|
-55 | -19.09 | -1.80 | -36.42 | 0 |
|
Net Income from Continuing Operations
|
-50,238.97 | -38,605.65 | -25,744.49 | -28,966.01 | -18,990.76 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-50,238.97 | -38,605.65 | -25,744.49 | -28,966.01 | -18,990.76 |
|
Non-Controlling/Minority Interests
|
25.97 | 29.51 | 241.95 | 745.21 | 501.14 |
|
Net Income after Non-Controlling/Minority Interests
|
-50,213.01 | -38,576.14 | -25,502.54 | -28,220.80 | -18,489.63 |
|
Net Income Available to Common Stockholders
|
-50,213.01 | -38,576.14 | -25,502.54 | -28,220.80 | -18,489.63 |
|
Diluted Net Income Available to Common Stockholders
|
-50,213.01 | -38,576.14 | -25,502.54 | -28,220.80 | -18,489.63 |
| Basic EPS
|
-1.02 | -1.03 | -0.76 | -1.17 | -0.96 |
| Diluted EPS
|
-1.02 | -1.03 | -0.76 | -1.17 | -0.96 |
|
Basic Weighted Average Shares Outstanding
|
52,797.30 | 39,956.13 | 33,930.58 | 24,146.62 | 19,285.45 |
|
Diluted Weighted Average Shares Outstanding
|
52,797.30 | 39,956.13 | 33,930.58 | 24,146.62 | 19,285.45 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-53,497.08 | -39,999.08 | -26,299.06 | -28,622.38 | -18,439.71 |
|
EBITDA
|
-53,136.20 | -39,761.36 | -26,127.34 | -28,466.85 | -18,291.81 |
|
Normalized EBITDA
|
-45,028.02 | -29,155 | -23,611.36 | -26,277.76 | -16,018.67 |
|
Normalized Income
|
-43,347.02 | -29,590.24 | -23,605.91 | -27,350.68 | -16,717.62 |
|
Total Unusual Items
|
8,108.18 | 10,606.36 | 2,515.98 | 2,189.09 | 2,273.15 |
|
Total Unusual Items Excluding Goodwill
|
8,108.18 | 10,606.36 | 2,515.98 | 2,189.09 | 2,273.15 |
12/31/2022 - 3/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade